Isocyanates, polyurethane and childhood asthma

Pediatric Allergy and Immunology

Volumn 16, Issue 5, 2005, Pages 368-379

  Krone, Cheryl A ^a   Klingner, Tom D ^b  

^a Applied Research Institute   (New Zealand)

^b Colormetric Laboratories ^*  (United States)

Author keywords

Childhood asthma; Dermal exposure; Methylenediphenyl diisocyanate; Skin sensitization; Synthetic bedding; Toluene diisocyanate

Indexed keywords

FOOD ALLERGEN; HAPTEN; ISOCYANIC ACID DERIVATIVE; POLYURETHAN; POLYURETHAN FOAM; TRIMELLITIC ANHYDRIDE;

AIR POLLUTANT; ASTHMA; ATOPY; BREAST ENDOPROSTHESIS; CONTACT DERMATITIS; DERMATOPHAGOIDES PTERONYSSINUS; ENVIRONMENTAL EXPOSURE; GENETIC MARKER; GUINEA PIG; HUMAN; HYPERSENSITIVITY REACTION; IMMUNE RESPONSE; LIFESTYLE; NONHUMAN; OCCUPATIONAL ASTHMA; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SKIN SENSITIVITY; TH1 CELL; TH2 CELL; WHEEZING;

ADULT; ASTHMA; CHILD; CONSUMER PRODUCT SAFETY; ENVIRONMENTAL EXPOSURE; HUMANS; HYPERSENSITIVITY; ISOCYANATES; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; POLYURETHANES; SKIN;

EID: 23944450533     PISSN: 09056157     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2005.00295.x     Document Type: Review

References (77)

1. ROSENSTOCK L, CULLEN MR (eds). Textbook of Clinical, Occupational And Environmental Medicine. Philadelphia: Saunders Publishers, 1994: 794-6.
2. LEVY BS, WEGMAN DH (eds). Occupational Health: Recognizing And Preventing Work-Related Diseases. 2nd edn. Boston/Toronto: Little, Brown and Co., 1988: 640.
3. TARLO SM, LISS GM. Diisocyanate-induced asthma: diagnosis, prognosis, and effects of medical surveillance measures. Appl Occup Environ Hyg 2002: 17: 902-8.
4. OTT MG, DILLER WF, JOLLY AT. Respiratory effects of toluene diisocyanate in the workplace: a discussion of exposure-response relationships. Crit Rev Toxicol 2003: 33: 1-59.
5. LIU Q, WISNEWSKI AV. Recent developments in diisocyanate asthma. Ann All Asthma Immunol 2003: 90(Suppl. 2): 35-41.
6. GOOSSENS A, DETIENNE T, BRUZE M. Occupational allergic contact dermatitis caused by isocyanates. Contact Dermat 2002: 47: 304-8.
7. WIRPSZA Z. Polyurethanes: Chemistry, Technology And Applications. New York: Ellis Horwood Publishers 1993: 517.
8. LANDROCK AH (ed.). Handbook of plastic foams: types, properties, manufacture and applications. Park Ridge, New Jersey: Noyes Publishers 1995: 488.
9. DARCEY D, LIPSCOMB HJ, EPLING C, PATE W, CHERRY LP, BERNSTEIN J. Clinical findings for residents near a polyurethane foam manufacturing plant. Arch Environ Health 2002: 57: 239-46.
10. COURTNEY D. Health hazards of soft soldering in the electronics industry. Rev Environ Health 1985: 5: 1-26.
11. WHITE WG, MORRIS MJ, SUGDEN E, ZAPATA E. Isocyanate-induced asthma in a car factory. Lancet 1980: 1: 756-60.
12. LITTORIN M, WELINDER H, SKARPING G, DALENE M, SKERFVING S. Exposure and nasal inflammation in workers heating polyurethane. Int Arch Occup Environ Health 2002: 75: 468-74.
13. LEGRIS M, TRUCOT A, LESAGE J, BELLEMARE D, PRUD'HOMME H. Isocyanates: Contamination Through Skin Contact. Hull, Quebec: AQHSST 1996.
14. KAROL MH, HAUTH BA, RILEY EJ, MAGRENI CM. Dermal contact with toluene diisocyanate (TDI) produces respiratory tract hypersensitivity in guinea pigs. Toxicol Appl Pharmacol 1981: 58: 221-230.
15. KAROL MH, DIXON C, BRADY M, ALARIE Y. Immunologic sensitization and pulmonary hypersensitivity by repeated inhalation of aromatic isocyanates. Toxicol Appl Pharmacol 1980: 53: 260-70.
16. BICKIS U. Investigation of dermally induced airway hyperreactivity to toluene diisocyanate in guinea pigs (dissertation). Kingston, Canada: Department of Pharmacology and Toxicology, Queens University 1994.
17. DOE JE, HICKS R, MILBURN GM. Specific inhibition of contact sensitivity in the guinea pig following toluene diisocyanate inhalation. Int Arch All Appl Immun 1982: 68: 275-9.
18. DEARMAN RJ, BOTHAM PA. Inhalation exposure to respiratory sensitising chemicals down-regulates guinea pig IgE and pulmonary responses. Int Arch All Appl Immun 1990: 92: 425-32.
19. RATTRAY NJ, BOTHAM PA, HEXT PM, et al. Induction of respiratory hypersensitivity to diphenylmethane-4-4-diisocyanate (MDI) in guinea pigs. Influence route of exposure. Toxicology 1994: 88: 15-30.
20. KIMBER I. The role of the skin in the development of chemical respiratory hypersensitivity. Toxicol Lett 1996: 86: 89-92.
21. JANG A, CHOI I, KOH Y, MOON J, LEE K. Increase in airway hyperresponsiveness among workers exposed to methylene diphenyldiisocyanate compared to workers exposed to toluene diisocyanate at a petrochemical plant in Korea. Am J Ind Med 2000: 37: 663-7.
22. PETSONK EL, WANG ML, LEWIS DM, SIEGEL PD, HUSBERG BJ. Asthma-like symptoms in wood product plant workers exposed to methylene diphenyl diisocyanate. Chest 2000: 118: 1183-93.
23. BAUR X. Hypersensitivity pneumonitis (extrinsic allergic alveotitis) induced by isocyanates. Bochum, Germany: Professional Assoc Res Inst for Occup Med, Ruhr University 1994.
24. KRONE CA, KLINGNER T, ELY JTA. Polyurethanes and childhood asthma. Med Sci Monit 2003: 9: HY39-43.
25. RASTOGI SC. Analysis of diisocyanate monomers in chemical products containing polyurethanes by high pressure liquid chromatography. Chromatographia 1989: 28: 15-18.
26. CONTE A, COSSI G. Gas chromatographic determination of free toluene diisocyanate in flexible urethane foams. J Chromatog 1981: 213: 162-5.
27. JEDRZEJCZAK K, GAIND VS. Determination of free toluene diisocyanates in flexible polyurethane foams using negative chemical-ionizaton mass spectrometry. Analyst 1993: 118: 149-52.
28. VAN GHELUWE P, COLE KC, HEBRARD MJ, LEROUX J. Attenuated total reflectance infrared spectroscopic analysis of high index foams. J Cell Plast 1987: 23: 73-85.
29. HUGO JM, SPENCE MW, LICKLY TD. The determination of the ability of polyurethane foam to release diisocyanate into air. Appl Occup Environ Hyg 2000: 15: 512-9.
30. The Society of the Plastics Industry. Proposition 65 compliance workbook for TDI exposure, Section 3, calculating exposure levels: Summary. Washington DC: The Society of the Plastics Industry Inc. 1990.
31. DAMANT AP, JICKELLS SM, CASTLE L. Liquid chromatographic determination of residual isocyanate monomers in plastics intended for food contact use. J AIAC Intl 1995: 78: 711-8.
32. RANDO RJ, POOVEY HG, GIBSON RA. Evaluation of 9-methylamino- methylanthracene as a chemical label for total reactive isocyanate group: application to isocyanate oligomers, polyurethane prepolymers, and phosgene. J Liq Chrom 1995: 18: 2743-63.
33. KRONE CA, ELY JT, KLINGNER T, RANDO RJ. Isocyanates in flexible polyurethane foams. Bull Environ Contam Toxicol 2003: 70: 328-35.
34. STRACHAN DP, CAREY IM. The home environment and severe asthma in adolescence: a population based case-control study. Brit Med J 1995: 311: 1053-6.
35. WANG BH, CHANG BW, SARGEANT R, MANSON PN. Late capsular hematoma after breast reconstruction with polyurethane-covered implants. Plast Reconstr Surg 1998: 102: 450-2.
36. SHANKLIN DR, SMALLEY DL. Dynamics of wound healing after silicone device implantation. Exp Mol Pathol 1999: 67: 26-39.
37. KATZIN WE, FENG LJ, ABBUHL M, KLEIN MA. Phenotype of lymphocytes associated with the inflammatory reaction to silicone gel breast implants. Clin Diagn Lab Immunol 1996: 3: 156-61.
38. HERRICK CA, XU L, WISNEWSKI AV, DAS J, REDLICH CA, BOTTOMLY K. A novel mouse model of diisocyanate-induced asthma showing allergic-type inflammation in the lung after inhaled antigen challenge. J All Clin Immunol 2002: 109: 873-8.
39. ANONYMOUS Adverse reactions associated with midline catheters - United States, 1992-1995. Morb Mortal Wkly Rep 1996: 45: 101-3.
40. VANEK VW, KUPENSKY DT, THOMSON DJ. Hypersensitivity-like reactions related to insertion of aquavene-based midline and PICC catheters. J Intraven Nurs 1997: 20: 23-7.
41. SILVERSTEIN B, WITKIN KM, FRANKOS VH, TERR AI. Assessing the role of the biomaterial Aquavene in patient reactions to Landmark midline catheters. Regul Toxicol Pharmacol 1997: 25: 60-7.
42. STRACHAN D, CAREY IM. Reduced risk of wheezing in children using feather pillows is confirmed. Brit Med J 1997: 314: 518.
43. FROSCH AC, SANDHU G, JOYCE R, STRACHAN DP. Prevalence of rhinitis, pillow type and past and present ownership of furred pets. Clin Exp All 1999: 29: 457-60.
44. YEMANEBERHAN H, BEKELE Z, VENN A, LEWIS S, PARRY E, BRITTON J. Prevalence of wheeze and asthma and relation to atopy in urban and rural Ethiopia. Lancet 1997: 350: 85-90.
45. SIEBERS R, FITZHARRIS P, CRANE J. Feather bedding and allergic disease in children: a cover story? Clin Exp All 2002: 32: 1119-23.
46. BUTLAND BK, STRACHAN DP, ANDERSON HR. The home environment and asthma symptoms in childhood: two population based case-control studies 13 years apart. Thorax 1997: 52: 618-24.
47. PONSONBY A-L, GATENBY P, GLASGOW N, MULLINS R, HURWITZ M, MCDONALD T. The association between synthetic bedding and adverse respiratory outcomes among skin-prick test positive and skin-prick test negative children. Allergy 2002: 57: 247-53.
48. KARAMAN O, UGUZ A, UZUNER N. Risk factors in wheezing infants. Pediatr Int 1999: 41: 147-50.
49. Centers for Disease Control and Prevention. Surveillance for asthma - United States, 1960-1995. CDC Surveill Summ 1998: 47: 1-28.
50. JINOT J, BAYARD S. Respiratory health effects of exposure to environmental tobacco smoke. Rev Environ Health 1996: 11: 89-100.
51. STEERENBERG PA, VAN AMSTERDAM JG, VANDEBRIEL RJ, VOS JG, VAN BREE L, VAN LOVEREN H. Environmental and lifestyle factors may act in concert to increase the prevalence of respiratory allergy including asthma. Clin Exp All 1999: 29: 1303-8.
52. PEDEN DB. Development of atopy and asthma: candidate environmental influences and important periods of exposure. Environ Health Perspect 2000: 108(Suppl. 3): 475-82.
53. STRACHAN DP. Hay fever, hygiene, and household size. Brit Med J 1989: 299: 1259-60.
54. PRESCOTT SL, MACAUBAS C, SMALLACOMBE T, HOLT BJ, SLY PD, HOLT PG. Development of allergen-specific T-cell memory in atopic and normal children. Lancet 1999: 353: 196-200.
55. LEMANSKE RF Jr. Issues in understanding pediatric asthma: epidemiology and genetics. J All Clin Immunol 2002: 109(Suppl.): S521-4.
56. BUSSE WW, ROSENWASSER LJ. Mechanisms of asthma. J Allergy Clin Immunol 2003: 111: S799-804.
57. SUDO N, SAWAMURA S-A, TANAKA K, AIBA Y, KUBO C, DOGA Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997: 159: 1739-45.
58. PERONI DG, CHATZIMICHAIL A, BONER AL. Food allergy: what can be done to prevent progression to asthma? Ann Allergy Asthma Immunol 2002: 89(Suppl. 1): 44-51.
59. LACK G, FOX D, NORTHSTONE K, GOLDING J. Avon longitudinal study of parents and children study team. Factors associated with the development of peanut allergy in childhood. N Engl J Med 2003: 348: 977-85.
60. SALOGA J, KNOP J. Does sensitization through the skin occur? Allergy 2000: 55: 905-9.
61. HAYES BB, AFSHARI A, MILLECCHIA L, WILLARD PA, POVOSKI SP, MEADE BJ. Evaluation of percutaneous penetration of natural rubber latex proteins. Toxicol Sci 2000: 56: 262-70.
62. DENDA M, WOOD LC, EMAMI S, et al. The epidermal hyperplasia associated with repeated barrier disruption by acetone treatment or tape stripping cannot be attributed to increased water loss. Arch Dermatol Res 1996: 288: 230-8.
63. ESTLANDER T, KESKINEN H, JOLANKI R, KANERVA L. Occupational dermatitis from exposure to polyurethane chemicals. Contact Dermat 1992: 27: 161-5.
64. ZISSU D, BINET S, LIMASSET J-D. Cutaneous sensitization to some polyisocyanate prepolymers in guinea pigs. Contact Dermat 1998: 39: 248-51.
65. MAESTRELLI P, DI STEFANO A, OCCARI P, et al. Cytokines in the airway mucosa of subjects with asthma induced by toluene diisocyanate. Am J Respir Crit Care Med 1995: 151: 607-12.
66. MAESTRELLI P, OCCARI P, TURATO G, et al. Expression of interleukin (IL)-4 and IL-5 proteins in asthma induced by toluene diisocyanate (TDI). Clin Exp All 1997: 27: 1292-98.
67. MAPP CE, BALBONI A, BARICORDI R, FABBRI LM. Human leukocyte antigen associations in occupational asthma induced by isocyanates. Am J Respir Crit Care Med 1997: 156: S139-43.
68. TEE RD, CULLINAN P, WELCH J, BURGE PS, NEWMAN-TAYLOR A. Specific IgE to isocyanates: a useful diagnostic role in occupational asthma. J All Clin Immunol 1998: 101: 709-15.
69. MAPP CE, FRYER AA, DE MARZO N, et al. Glutathione S-transferase GTSP1 is a susceptibility gene for occupational asthma induced by isocyanates. J All Clin Immunol 2002: 109: 867-72.
70. POPP W, RAUSCHER H, SERTL K, WANKE T, ZWICK H. Risk factors for sensitization to furred pets. Allergy 1990: 45: 75-9.
71. ALMQVIST C, EGMAR AC, HEDLIN G, et al. Direct and indirect exposure to pets - risk of sensitization and asthma at 4 years in a birth cohort. Clin Exp All 2003: 33: 1190-7.
72. TREPKA MJ, HEINRICH J, WICHMANN HE. The epidemiology of atopic diseases in Germany: an east-west comparison. Rev Environ Health 1996: 11: 119-31.
73. PARK HS, FREW AJ. Genetic markers for occupational asthma. J All Clin Immunol 2002: 109: 774-6.
74. PARK HS, NAHM DH. Prognostic factors for TDI-induced occupational asthma after removal from exposure. Clin Exp All 1997: 27: 1145-50.
75. SEPAI O, HENSCHLER D, CZECH S, ECKERT P, SABBIONI G. Exposure to toluenediamines from polyurethane-covered breast implants. Toxicol Lett 1995: 77: 371-8.
76. SCHWAB M, MCDERMOTT A, SPENGLER JD. Using longitudinal data to understand children's activity patterns in an exposure context: data from the Kanawha County Health Study. Environ Int 1992: 18: 173-89.
77. BROADfIELD E, MCKEEVER TM, SCRIVENER S, VENN A, LEWIS SA, BRITTON J. Increase in the prevalence of allergen skin sensitization in successive birth cohorts. J All Clin Immunol 2002: 109: 969-74.